Recursion Pharmaceuticals is up a bit on the day, funds flowing in kept the price up 1.27% since yesterday.
Currently RXRX isn't at a clear support/resistance line that seems tradable. Recursion Pharmaceuticals hasn't shown a lot of strength recently, shareholders don't seem that energized about the asset's future prospects. RXRX might find some support at the 3.91 level, buyers might push the price back up from here. But it's not very clear what will happen.